Troutman Pepper Hamilton Sanders advised Context Therapeutics Inc. on the deal.Context Therapeutics Inc., a women’s oncology company developing advanced small molecule and immunotherapy treatments to transform…
Context Therapeutics’ $28.75 Million IPO
